Summary
In a significant market movement during August 2021, Pepgen was the subject of a vc funding. The transaction achieved a gross valuation of £80,753,165. Leading the round was Tudor Investment Corporation, Adage Capital Management, Oxford Sciences Innovation, Viking Global Investors, Gray’s Creek Capital Partners, Deerfield Management Company, Samsara Biocapital, RA Capital Management, CureDuchenne Ventures, Laurion Capital Management.
This transaction was brokered by an undisclosed advisor. The deal reflects ongoing market confidence within its sector.
Lead Investor / Acquirer
Tudor Investment Corporation
Lead Investor / Acquirer
Adage Capital Management
Lead Investor / Acquirer
Oxford Sciences Innovation
Lead Investor / Acquirer
Viking Global Investors
Lead Investor / Acquirer
Gray’s Creek Capital Partners
Lead Investor / Acquirer
Deerfield Management Company
Lead Investor / Acquirer
Samsara Biocapital
Lead Investor / Acquirer
RA Capital Management
Lead Investor / Acquirer
CureDuchenne Ventures
Lead Investor / Acquirer
Laurion Capital Management
Advising Broker
Undisclosed Firm
Related Deals in Healthcare & Biotech
Series A prioritisedOriginal Source
This funding round is sourced from the Tech.eu Funding Explorer. View the full record, investors, and citations there.
View on Tech.eu Funding ExplorerFunding data via Tech.eu Funding Explorer, licensed under CC BY 4.0. See our methodology.
AI Insight Lenses
ProAI-generated analysis from four professional perspectives. Powered by PE Deals.
Sign in to unlock AI Lenses
Sign in